Skip to content
“The pandemic has exposed our country’s dependence on other countries for essential prescription drugs,” began Steve Scully, contributing editor at The Hill and moderator […]
COVID-19 forced us to reimagine the pharma supply chain – and that’s a good thing Read More »
According to a recent assessment from the U.N. Food and Agriculture Organization (FAO), systemic reforms – as well as advancements in biotechnology – are
We can beat world hunger with systemic reforms and biotech, says FAO Read More »
Today marks the last day of Crohn’s and Colitis Awareness Week, an opportunity to highlight the plight of between 1.6 and 3.1 million Americans
What to know during Crohn’s and Colitis Awareness Week Read More »
The U.S. was solely responsible for 61% of medicines approved by the U.S. Food and Drug Administration (FDA) between 2011-2020, says a new report
55% of FDA-approved drugs were developed by U.S. small biotechs, says study Read More »
Infantile Spasm Awareness Week (ISAW) takes place in the first week of December, an important effort to raise awareness of infantile spasms, or IS.
Infantile spasms are a medical emergency – let’s help stop them Read More »
New data from the Centers for Disease Control and Prevention (CDC) show the updated (bivalent) boosters significantly increase protection against COVID-19. The problem? Most
Bivalent COVID boosters increase protection, CDC study finds Read More »
Wheat harvests will face pressure from climate change, scientists say. But biotechnology is working on ways to make it easier to put bread on
How biotech is making it easier to put bread on the table Read More »
December 5 marks the 8th World Soil Day, with the theme, “Soils, where food begins.” According to the Food and Agriculture Organization of the
World Soil Day recognizes ‘where food begins’ Read More »
National Influenza Vaccination Week is December 5–9 and serves as a reminder that it is never too late to get your flu vaccine—especially this
National Influenza Vaccination Week begins with warnings of a tough flu season Read More »
The results from the Phase III Clarity AD trial of lecanemab (BAN2401), the experimental Alzheimer’s drug developed by Eisai Co Ltd and Biogen, were
Lecanemab phase 3 trial results presented at Alzheimer’s conference Read More »
